BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34768528)

  • 1. Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes.
    Benetos G; Galanakos S; Koutagiar I; Skoumas I; Oikonomou G; Drakopoulou M; Karmpalioti M; Katsi V; Tsioufis C; Toutouzas K
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
    N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
    Kastelein JJ; Sager PT; de Groot E; Veltri E
    Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
    Derosa G; D'Angelo A; Franzetti IG; Ragonesi PD; Gadaleta G; Scalise F; Ciccarelli L; Piccinni MN; Cicero AF
    J Clin Pharm Ther; 2009 Jun; 34(3):267-76. PubMed ID: 19650249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up.
    Skoumas I; Ioakeimidis N; Vlachopoulos C; Chrysohoou C; Michalakeas C; Georgakopoulos C; Katsi V; Panagiotakos D; Tousoulis D
    Angiology; 2018 Mar; 69(3):242-248. PubMed ID: 28681648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
    Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
    Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
    van der Graaf A; Cuffie-Jackson C; Vissers MN; Trip MD; Gagné C; Shi G; Veltri E; Avis HJ; Kastelein JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1421-9. PubMed ID: 18940534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia.
    Toutouzas K; Skoumas J; Koutagiar I; Benetos G; Pianou N; Georgakopoulos A; Galanakos S; Antonopoulos A; Drakopoulou M; Oikonomou EK; Kafouris P; Athanasiadis E; Metaxas M; Spyrou G; Pallantza Z; Galiatsatos N; Aggeli C; Antoniades C; Keramida G; Peters AM; Anagnostopoulos CD; Tousoulis D
    J Clin Lipidol; 2018; 12(1):33-43. PubMed ID: 29174439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
    Gagné C; Gaudet D; Bruckert E;
    Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender is independently associated with increased carotid temperatures in patients with coronary artery disease.
    Benetos G; Toutouzas K; Matsoukis I; Drakopoulou M; Mitropoulou F; Koutagiar I; Nikolaou C; Stathogiannis K; Siores E; Tousoulis D
    Int J Cardiol; 2016 Sep; 219():130-5. PubMed ID: 27323338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
    Climent E; Marco-Benedí V; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Lafuente H; Ortega-Martínez de Victoria E; Brea-Hernando Á; Vila À; Civeira F; Pedro-Botet J
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1594-1603. PubMed ID: 33744038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
    de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee CW
    BMC Cardiovasc Disord; 2019 Aug; 19(1):201. PubMed ID: 31426749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Toutouzas K; Benetos G; Koutagiar I; Barampoutis N; Mitropoulou F; Davlouros P; Sfikakis PP; Alexopoulos D; Stefanadis C; Siores E; Tousoulis D
    Atherosclerosis; 2017 Jul; 262():25-30. PubMed ID: 28482222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis.
    Masoura C; Pitsavos C; Aznaouridis K; Skoumas I; Vlachopoulos C; Stefanadis C
    Atherosclerosis; 2011 Jan; 214(1):129-38. PubMed ID: 21074770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
    Bays HE; Patel MD; Mavros P; Ramey DR; Tomassini JE; Tershakovec AM; Baxter CA
    J Clin Lipidol; 2017; 11(4):929-937. PubMed ID: 28647412
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.